Chitose Hamari’s High Potency Drug Substance Manufacture Facility
Chitose Hamari’s peptide production facility for high potency drug substances has been operational since 2016. The facility is equipped with a clean room. Small peptides are manufactured under strict cGMP. Mid-length to long peptides from 10 to 30 residues, cyclic peptides, peptide conjugates, etc. can also be manufactured. Moreover, to respond to the increasing market demands for injection-grade APIs, the containment and cleanliness control systems was upgraded for high potency injection-grade peptides in February 2019. Chitose Hamari will evolve with your needs!